FIELD: chemistry.
SUBSTANCE: described are compounds of formula , where X, R1, R2, R3, R4 and R5 assume values given in the description and paragraphs of the formula of invention, and their pharmaceutically acceptable salts.
EFFECT: compounds have antagonistic activity on histamine receptor 3 (H3).
25 cl, 3 tbl, 215 ex
Title | Year | Author | Number |
---|---|---|---|
AZAINDOLE-2-CARBOXAMIDE DERIVATIVES | 2006 |
|
RU2417226C2 |
QUINOLINE DERIVATIVES | 2005 |
|
RU2391338C2 |
NAPHTHALENE DERIVATIVES SUITABLE FOR USE AS LIGANDS OF HISTAMINE 3 RECEPTORS | 2005 |
|
RU2387638C2 |
DERIVATIVES OF 1,1-DIOXOTHIOMORPHOLINYLINDOLYL METHANONE FOR USE AS HISTAMINASE MODULATORS | 2006 |
|
RU2412182C2 |
PIPERIZINYLPYRIDINE DERIVATIVES AS ANTI-OBESITY AGENTS | 2005 |
|
RU2386618C2 |
DERIVATIVES OF BENZIMIDAZOL INHIBITING FACTOR Xa | 2004 |
|
RU2346944C2 |
DIAMINOTHIAZOLES POSSESSING PROPERTY OF CYCLIN-DEPENDENT KINASE 4 INHIBITOR | 2003 |
|
RU2311414C2 |
2,5,7-SUBSTITUTED OXAZOLPYRIMIDINE DERIVATIVES | 2011 |
|
RU2557246C2 |
INDOLE-2-CARBOXAMIDES AS INHIBITORS OF FACTOR Xa AND/OR VIIa, MEDICINAL AGENT BASED ON THEREOF AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2299881C2 |
HETEROCYCLIC SUBSTITUTED PHENYLMETHANONES AS GLYCINE TRANSPORTER 1 INHIBITORS | 2006 |
|
RU2405771C2 |
Authors
Dates
2010-02-27—Published
2005-06-13—Filed